Paper1557230
Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.
Rodrigues Júnior V and 2 others. Parasite Immunol, 1992. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens. Papers, record 1557230. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1557230
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen-Presenting Cells | Major topic |
| Antigens, Protozoan | Major topic |
| Leishmania donovani | Major topic |
| Leishmaniasis, Visceral | Major topic |
| Lymphocyte Activation | Major topic |
| Spleen | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| Cricetinae | |
| Disease Models, Animal | |
| Immunity, Cellular | |
| Lymph Nodes | |
| Macrophages | |
| Mesocricetus |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33680991 | Role of Cytokines in Experimental and Human Visceral Leishmaniasis. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/33680991 | PubMed |
| 25745863 | Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis. | PLoS Negl Trop Dis | 2015 | https://conductscience.org/library/papers/25745863 | PubMed |
| 25144181 | Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/25144181 | PubMed |
| 24732039 | Combination of liposomal CpG oligodeoxynucleotide 2006 and miltefosine induces strong cell-mediated immunity during experimental visceral leishmaniasis. | PLoS One | 2014 | https://conductscience.org/library/papers/24732039 | PubMed |
| 24553602 | Animal models for the study of leishmaniasis immunology. | Rev Inst Med Trop Sao Paulo | 2014 | https://conductscience.org/library/papers/24553602 | PubMed |
| 24475071 | Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis. | PLoS One | 2014 | https://conductscience.org/library/papers/24475071 | PubMed |
| 23369975 | Experimental models in vaccine research: malaria and leishmaniasis. | Braz J Med Biol Res | 2013 | https://conductscience.org/library/papers/23369975 | PubMed |
| 22539989 | Evaluation of Leishmania donovani protein disulfide isomerase as a potential immunogenic protein/vaccine candidate against visceral Leishmaniasis. | PLoS One | 2012 | https://conductscience.org/library/papers/22539989 | PubMed |
| 22292030 | Leishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamsters. | PLoS One | 2012 | https://conductscience.org/library/papers/22292030 | PubMed |
| 19053149 | Photodynamic vaccination of hamsters with inducible suicidal mutants of Leishmania amazonensis elicits immunity against visceral leishmaniasis. | Eur J Immunol | 2009 | https://conductscience.org/library/papers/19053149 | PubMed |
| 10692051 | Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen. | Immunology | 2000 | https://conductscience.org/library/papers/10692051 | PubMed |
| 9488418 | Transforming growth factor beta and immunosuppression in experimental visceral leishmaniasis. | Infect Immun | 1998 | https://conductscience.org/library/papers/9488418 | PubMed |
| 7595213 | Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. | J Exp Med | 1995 | https://conductscience.org/library/papers/7595213 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1557230
GET https://conductscience.org/api/papers/v1/1557230/authors